In Vitro Anti- Malassezia Activity of Castanea crenata Shell and Oil-Soluble Glycyrrhiza Extracts

A new shampoo with anti- properties obtained from various plants is required to provide seborrheic dermatitis patients with a wider range of treatment options. The aim of this study was to obtain susceptibility profiles of and , the most important pathogenic organisms in the development of seborrhei...

Full description

Saved in:
Bibliographic Details
Published inAnnals of dermatology Vol. 29; no. 3; pp. 321 - 326
Main Authors Han, Song Hee, Hur, Min Seok, Kim, Min Jung, Jung, Won Hee, Park, Minji, Kim, Jeong Hwan, Shin, Hong Ju, Choe, Yong Beom, Ahn, Kyu Joong, Lee, Yang Won
Format Journal Article
LanguageEnglish
Published Korea (South) The Korean Dermatological Association; The Korean Society for Investigative Dermatology 01.06.2017
대한피부과학회
Subjects
Online AccessGet full text
ISSN1013-9087
2005-3894
DOI10.5021/ad.2017.29.3.321

Cover

Abstract A new shampoo with anti- properties obtained from various plants is required to provide seborrheic dermatitis patients with a wider range of treatment options. The aim of this study was to obtain susceptibility profiles of and , the most important pathogenic organisms in the development of seborrheic dermatitis, to the plant extracts used in commercial anti-dandruff shampoos. Minimal inhibitory concentrations (MICs) were determined for eight candidate plant extracts and two plant-derived natural products diluted with Leeming and Notman medium to final concentrations of 0.016 to 1 mg/ml. shell, leaf, and oil-soluble extracts presented relatively low MIC values (≤0.5 mg/ml) against both strains. The shell and oil-soluble extracts demonstrated especially high activity, suggesting their potential use in the treatment of seborrheic dermatitis. The extracts also showed fungistatic activity against other common facultative pathogenic yeasts, and . shell and oil-soluble extracts could potentially be used as active ingredients in anti-seborrheic and anti-dandruff shampoo formulations. They could be helpful for repeated treatments and regular prophylaxis of scalp seborrheic dermatitis.
AbstractList Background: A new shampoo with anti-Malassezia properties obtained from various plants is required to provide seborrheic dermatitis patients with a wider range of treatment options. Objective: The aim of this study was to obtain in vitro susceptibility profiles of Malassezia restricta and M. globosa, the most important pathogenic organisms in the development of seborrheic dermatitis, to the plant extracts used in commercial anti-dandruff shampoos. Methods: Minimal inhibitory concentrations (MICs) were determined for eight candidate plant extracts and two plant-derived natural products diluted with Leeming and Notman medium to final concentrations of 0.016 to 1 mg/ml. Results: Castanea crenata shell, Camellia sinensis leaf, and oil-soluble Glycyrrhiza extracts presented relatively low MIC values (≤0.5 mg/ml) against both strains. The C. crenata shell and oil-soluble Glycyrrhiza extracts demonstrated especially high anti-Malassezia activity, suggesting their potential use in the treatment of seborrheic dermatitis. The extracts also showed fungistatic activity against other common facultative pathogenic yeasts, Cryptococcus and Candida. Conclusion: C. crenata shell and oil-soluble Glycyrrhiza extracts could potentially be used as active ingredients in anti-seborrheic and anti-dandruff shampoo formulations. They could be helpful for repeated treatments and regular prophylaxis of scalp seborrheic dermatitis. KCI Citation Count: 1
A new shampoo with anti-Malassezia properties obtained from various plants is required to provide seborrheic dermatitis patients with a wider range of treatment options.BACKGROUNDA new shampoo with anti-Malassezia properties obtained from various plants is required to provide seborrheic dermatitis patients with a wider range of treatment options.The aim of this study was to obtain in vitro susceptibility profiles of Malassezia restricta and M. globosa, the most important pathogenic organisms in the development of seborrheic dermatitis, to the plant extracts used in commercial anti-dandruff shampoos.OBJECTIVEThe aim of this study was to obtain in vitro susceptibility profiles of Malassezia restricta and M. globosa, the most important pathogenic organisms in the development of seborrheic dermatitis, to the plant extracts used in commercial anti-dandruff shampoos.Minimal inhibitory concentrations (MICs) were determined for eight candidate plant extracts and two plant-derived natural products diluted with Leeming and Notman medium to final concentrations of 0.016 to 1 mg/ml.METHODSMinimal inhibitory concentrations (MICs) were determined for eight candidate plant extracts and two plant-derived natural products diluted with Leeming and Notman medium to final concentrations of 0.016 to 1 mg/ml.Castanea crenata shell, Camellia sinensis leaf, and oil-soluble Glycyrrhiza extracts presented relatively low MIC values (≤0.5 mg/ml) against both strains. The C. crenata shell and oil-soluble Glycyrrhiza extracts demonstrated especially high anti-Malassezia activity, suggesting their potential use in the treatment of seborrheic dermatitis. The extracts also showed fungistatic activity against other common facultative pathogenic yeasts, Cryptococcus and Candida.RESULTSCastanea crenata shell, Camellia sinensis leaf, and oil-soluble Glycyrrhiza extracts presented relatively low MIC values (≤0.5 mg/ml) against both strains. The C. crenata shell and oil-soluble Glycyrrhiza extracts demonstrated especially high anti-Malassezia activity, suggesting their potential use in the treatment of seborrheic dermatitis. The extracts also showed fungistatic activity against other common facultative pathogenic yeasts, Cryptococcus and Candida.C. crenata shell and oil-soluble Glycyrrhiza extracts could potentially be used as active ingredients in anti-seborrheic and anti-dandruff shampoo formulations. They could be helpful for repeated treatments and regular prophylaxis of scalp seborrheic dermatitis.CONCLUSIONC. crenata shell and oil-soluble Glycyrrhiza extracts could potentially be used as active ingredients in anti-seborrheic and anti-dandruff shampoo formulations. They could be helpful for repeated treatments and regular prophylaxis of scalp seborrheic dermatitis.
A new shampoo with anti- properties obtained from various plants is required to provide seborrheic dermatitis patients with a wider range of treatment options. The aim of this study was to obtain susceptibility profiles of and , the most important pathogenic organisms in the development of seborrheic dermatitis, to the plant extracts used in commercial anti-dandruff shampoos. Minimal inhibitory concentrations (MICs) were determined for eight candidate plant extracts and two plant-derived natural products diluted with Leeming and Notman medium to final concentrations of 0.016 to 1 mg/ml. shell, leaf, and oil-soluble extracts presented relatively low MIC values (≤0.5 mg/ml) against both strains. The shell and oil-soluble extracts demonstrated especially high activity, suggesting their potential use in the treatment of seborrheic dermatitis. The extracts also showed fungistatic activity against other common facultative pathogenic yeasts, and . shell and oil-soluble extracts could potentially be used as active ingredients in anti-seborrheic and anti-dandruff shampoo formulations. They could be helpful for repeated treatments and regular prophylaxis of scalp seborrheic dermatitis.
Author Hur, Min Seok
Kim, Min Jung
Jung, Won Hee
Han, Song Hee
Kim, Jeong Hwan
Choe, Yong Beom
Park, Minji
Ahn, Kyu Joong
Lee, Yang Won
Shin, Hong Ju
AuthorAffiliation 3 AmorePacific R&D Center, Yongin, Korea
4 Research Institute of Medical Science, Konkuk University, Seoul, Korea
1 Department of Dermatology, Konkuk University School of Medicine, Seoul, Korea
2 Department of Systems Biotechnology, Chung-Ang University, Anseong, Korea
AuthorAffiliation_xml – name: 4 Research Institute of Medical Science, Konkuk University, Seoul, Korea
– name: 1 Department of Dermatology, Konkuk University School of Medicine, Seoul, Korea
– name: 2 Department of Systems Biotechnology, Chung-Ang University, Anseong, Korea
– name: 3 AmorePacific R&D Center, Yongin, Korea
Author_xml – sequence: 1
  givenname: Song Hee
  surname: Han
  fullname: Han, Song Hee
  organization: Department of Dermatology, Konkuk University School of Medicine, Seoul, Korea
– sequence: 2
  givenname: Min Seok
  surname: Hur
  fullname: Hur, Min Seok
  organization: Department of Dermatology, Konkuk University School of Medicine, Seoul, Korea
– sequence: 3
  givenname: Min Jung
  surname: Kim
  fullname: Kim, Min Jung
  organization: Department of Dermatology, Konkuk University School of Medicine, Seoul, Korea
– sequence: 4
  givenname: Won Hee
  surname: Jung
  fullname: Jung, Won Hee
  organization: Department of Systems Biotechnology, Chung-Ang University, Anseong, Korea
– sequence: 5
  givenname: Minji
  surname: Park
  fullname: Park, Minji
  organization: Department of Systems Biotechnology, Chung-Ang University, Anseong, Korea
– sequence: 6
  givenname: Jeong Hwan
  surname: Kim
  fullname: Kim, Jeong Hwan
  organization: AmorePacific R&D Center, Yongin, Korea
– sequence: 7
  givenname: Hong Ju
  surname: Shin
  fullname: Shin, Hong Ju
  organization: AmorePacific R&D Center, Yongin, Korea
– sequence: 8
  givenname: Yong Beom
  surname: Choe
  fullname: Choe, Yong Beom
  organization: Department of Dermatology, Konkuk University School of Medicine, Seoul, Korea., Research Institute of Medical Science, Konkuk University, Seoul, Korea
– sequence: 9
  givenname: Kyu Joong
  surname: Ahn
  fullname: Ahn, Kyu Joong
  organization: Department of Dermatology, Konkuk University School of Medicine, Seoul, Korea., Research Institute of Medical Science, Konkuk University, Seoul, Korea
– sequence: 10
  givenname: Yang Won
  surname: Lee
  fullname: Lee, Yang Won
  organization: Department of Dermatology, Konkuk University School of Medicine, Seoul, Korea., Research Institute of Medical Science, Konkuk University, Seoul, Korea
BackLink https://www.ncbi.nlm.nih.gov/pubmed/28566909$$D View this record in MEDLINE/PubMed
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002227025$$DAccess content in National Research Foundation of Korea (NRF)
BookMark eNp1kc1vEzEUxC1URNPCnRPykR52ebb3yxekKCptpKJKtHC13nq9xNTxFtupSP_6Ok2LAInTO3jmN9bMETnwkzeEvGVQ1sDZBxxKDqwtuSxFKTh7QWYcoC5EJ6sDMmPARCGhaw_JUYw_ABrGW_aKHPKubhoJckZw6ek3m8JE5z7Zgn5GhzGae4t0rpO9s2lLp5EuMCb0BqkOxmNCerUyzlH0A720rria3KZ3hp65rd6GsLL3SE9_pYA6xdfk5YgumjdP95h8_XR6vTgvLi7Plov5RaFF16VCMqwAeMcrrE1v2hqHoWtHMUCrm1pKpntZtwiAnWh65BWv-wrkiI0Ze9GAOCYne64Po7rRVk1oH-_3Sd0ENf9yvVRMtB1vRdZ-3GtvN_3aDNr4_FenboNdY9g-Ov9-8XaVOXeqrnK1QmbA-ydAmH5uTExqbaPOleSSpk1UTEIlgTGxy3r3Z9bvkOcNsqDZC3SYYgxmVNomTHbaRVunGKjd2AoHtRtbcamEymNnI_xjfGb_1_IAOA-sMQ
CitedBy_id crossref_primary_10_1371_journal_pone_0291363
crossref_primary_10_2174_1568026622666220531120226
crossref_primary_10_1111_jocd_16219
crossref_primary_10_1093_mmy_myaa087
crossref_primary_10_1016_j_micpath_2025_107323
crossref_primary_10_1002_ptr_6974
crossref_primary_10_1186_s13765_021_00670_x
crossref_primary_10_2147_CCID_S376700
Cites_doi 10.2165/00003495-199754050-00002
10.1080/16537150601092944
10.1080/00015550260132433
10.1002/ptr.2726
10.1111/ics.12007
10.1001/archderm.1976.01630330015002
10.1128/AAC.40.2.279
10.1111/j.1365-2133.2004.06208.x
10.1111/1523-1747.ep12512335
10.1128/JCM.43.6.2824-2829.2005
10.5021/ad.2014.26.6.733
10.1111/myc.12456
10.1007/s13197-015-2131-6
10.1128/JCM.25.10.2017-2019.1987
10.1038/sj.jid.5701017
10.1016/S1389-1723(01)80016-5
10.1016/j.clindermatol.2003.08.003
10.1016/S1369-5274(98)80087-8
10.1097/00001432-200204000-00006
10.1111/ics.12098
10.5021/ad.2011.23.2.156
10.1159/000066452
10.1007/BF02980125
10.1111/myc.12076
ContentType Journal Article
Copyright Copyright © 2017 The Korean Dermatological Association and The Korean Society for Investigative Dermatology 2017
Copyright_xml – notice: Copyright © 2017 The Korean Dermatological Association and The Korean Society for Investigative Dermatology 2017
DBID AAYXX
CITATION
NPM
7X8
5PM
ACYCR
DOI 10.5021/ad.2017.29.3.321
DatabaseName CrossRef
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
Korean Citation Index
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
PubMed
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2005-3894
EndPage 326
ExternalDocumentID oai_kci_go_kr_ARTI_1378273
PMC5438939
28566909
10_5021_ad_2017_29_3_321
Genre Journal Article
GrantInformation_xml – fundername: ;
GroupedDBID 23M
5-W
53G
5GY
85H
8JR
8XY
9ZL
AAYXX
ACYCR
ADBBV
AENEX
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
C1A
CITATION
DIK
E3Z
EF.
F5P
HYE
HZB
MZR
OK1
RPM
TR2
ZZE
M~E
NPM
7X8
5PM
ID FETCH-LOGICAL-c388t-91a4002824a5ebe75add87f3d07c65991cb957a00a836ba2425b409fa6efb3603
ISSN 1013-9087
IngestDate Tue Nov 21 21:38:34 EST 2023
Tue Sep 30 16:59:05 EDT 2025
Thu Sep 04 17:25:32 EDT 2025
Thu Jan 02 22:20:48 EST 2025
Wed Oct 01 03:37:39 EDT 2025
Thu Apr 24 22:58:46 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed false
IsScholarly true
Issue 3
Keywords Shampoo
Seborrheic dermatitis
Malassezia
Oil-soluble Glycyrrhiza extract
Castanea crenata shell extract
Language English
License This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c388t-91a4002824a5ebe75add87f3d07c65991cb957a00a836ba2425b409fa6efb3603
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://pubmed.ncbi.nlm.nih.gov/PMC5438939
PMID 28566909
PQID 1904901133
PQPubID 23479
PageCount 6
ParticipantIDs nrf_kci_oai_kci_go_kr_ARTI_1378273
pubmedcentral_primary_oai_pubmedcentral_nih_gov_5438939
proquest_miscellaneous_1904901133
pubmed_primary_28566909
crossref_citationtrail_10_5021_ad_2017_29_3_321
crossref_primary_10_5021_ad_2017_29_3_321
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2017-06-01
PublicationDateYYYYMMDD 2017-06-01
PublicationDate_xml – month: 06
  year: 2017
  text: 2017-06-01
  day: 01
PublicationDecade 2010
PublicationPlace Korea (South)
PublicationPlace_xml – name: Korea (South)
PublicationTitle Annals of dermatology
PublicationTitleAlternate Ann Dermatol
PublicationYear 2017
Publisher The Korean Dermatological Association; The Korean Society for Investigative Dermatology
대한피부과학회
Publisher_xml – name: The Korean Dermatological Association; The Korean Society for Investigative Dermatology
– name: 대한피부과학회
References Piérard-Franchimont (10.5021/ad.2017.29.3.321_ref11) 2002; 15
Nenoff (10.5021/ad.2017.29.3.321_ref15) 2002; 82
Gupta (10.5021/ad.2017.29.3.321_ref2) 2003; 21
Carrillo-Muñoz (10.5021/ad.2017.29.3.321_ref6) 2013; 56
McGinley (10.5021/ad.2017.29.3.321_ref14) 1975; 64
Onlom (10.5021/ad.2017.29.3.321_ref23) 2014; 36
Crespo Erchiga (10.5021/ad.2017.29.3.321_ref1) 2002; 15
Guého (10.5021/ad.2017.29.3.321_ref5) 1998; 36
Kim (10.5021/ad.2017.29.3.321_ref8) 2014; 26
Kim (10.5021/ad.2017.29.3.321_ref16) 2016; 59
Turner (10.5021/ad.2017.29.3.321_ref7) 2013; 35
Sugita (10.5021/ad.2017.29.3.321_ref10) 2005; 43
Alexander (10.5021/ad.2017.29.3.321_ref18) 1997; 54
Leeming (10.5021/ad.2017.29.3.321_ref9) 1987; 25
Ratnavel (10.5021/ad.2017.29.3.321_ref12) 2007; 18
Georgopapadakou (10.5021/ad.2017.29.3.321_ref19) 1998; 1
du Vivier (10.5021/ad.2017.29.3.321_ref22) 1976; 112
Hahn (10.5021/ad.2017.29.3.321_ref24) 2004; 27
Rigopoulos (10.5021/ad.2017.29.3.321_ref21) 2004; 151
Arrese (10.5021/ad.2017.29.3.321_ref13) 1996; 58
Fatima (10.5021/ad.2017.29.3.321_ref20) 2009; 23
Sato (10.5021/ad.2017.29.3.321_ref26) 2000; 90
Tajima (10.5021/ad.2017.29.3.321_ref3) 2008; 128
Rohinishree (10.5021/ad.2017.29.3.321_ref25) 2016; 53
Lee (10.5021/ad.2017.29.3.321_ref4) 2011; 23
Georgopapadakou (10.5021/ad.2017.29.3.321_ref17) 1996; 40
25473226 - Ann Dermatol. 2014 Dec;26(6):733-8
8834867 - Antimicrob Agents Chemother. 1996 Feb;40(2):279-91
999300 - Arch Dermatol. 1976 Sep;112(9):1245-8
21747613 - Ann Dermatol. 2011 May;23(2):156-61
12353705 - Acta Derm Venereol. 2002;82(3):170-3
17671514 - J Invest Dermatol. 2008 Feb;128(2):345-51
14678722 - Clin Dermatol. 2003 Sep-Oct;21(5):417-25
16232887 - J Biosci Bioeng. 2000;90(4):442-6
3667925 - J Clin Microbiol. 1987 Oct;25(10):2017-9
11964913 - Curr Opin Infect Dis. 2002 Apr;15(2):133-42
22970742 - Int J Cosmet Sci. 2013 Feb;35(1):78-83
26786542 - Mycoses. 2016 May;59(5):274-80
12476017 - Skin Pharmacol Appl Skin Physiol. 2002 Nov-Dec;15(6):434-41
24117781 - Int J Cosmet Sci. 2014 Feb;36(1):74-8
10066533 - Curr Opin Microbiol. 1998 Oct;1(5):547-57
237965 - J Invest Dermatol. 1975 Jun;64(6):401-5
15956404 - J Clin Microbiol. 2005 Jun;43(6):2824-9
17520465 - J Dermatolog Treat. 2007;18(2):88-96
19170157 - Phytother Res. 2009 Aug;23(8):1190-3
9988511 - Med Mycol. 1998;36 Suppl 1:220-9
8886540 - Cutis. 1996 Sep;58(3):235-7
23496653 - Mycoses. 2013 Sep;56(5):571-5
15202557 - Arch Pharm Res. 2004 May;27(5):518-23
27162389 - J Food Sci Technol. 2016 Feb;53(2):1092-100
15541087 - Br J Dermatol. 2004 Nov;151(5):1071-5
9360056 - Drugs. 1997 Nov;54(5):657-78
References_xml – volume: 54
  start-page: 657
  year: 1997
  ident: 10.5021/ad.2017.29.3.321_ref18
  publication-title: Drugs
  doi: 10.2165/00003495-199754050-00002
– volume: 18
  start-page: 88
  year: 2007
  ident: 10.5021/ad.2017.29.3.321_ref12
  publication-title: J Dermatolog Treat
  doi: 10.1080/16537150601092944
– volume: 82
  start-page: 170
  year: 2002
  ident: 10.5021/ad.2017.29.3.321_ref15
  publication-title: Acta Derm Venereol
  doi: 10.1080/00015550260132433
– volume: 23
  start-page: 1190
  year: 2009
  ident: 10.5021/ad.2017.29.3.321_ref20
  publication-title: Phytother Res
  doi: 10.1002/ptr.2726
– volume: 35
  start-page: 78
  year: 2013
  ident: 10.5021/ad.2017.29.3.321_ref7
  publication-title: Int J Cosmet Sci
  doi: 10.1111/ics.12007
– volume: 112
  start-page: 1245
  year: 1976
  ident: 10.5021/ad.2017.29.3.321_ref22
  publication-title: Arch Dermatol
  doi: 10.1001/archderm.1976.01630330015002
– volume: 40
  start-page: 279
  year: 1996
  ident: 10.5021/ad.2017.29.3.321_ref17
  publication-title: Antimicrob Agents Chemother
  doi: 10.1128/AAC.40.2.279
– volume: 151
  start-page: 1071
  year: 2004
  ident: 10.5021/ad.2017.29.3.321_ref21
  publication-title: Br J Dermatol
  doi: 10.1111/j.1365-2133.2004.06208.x
– volume: 64
  start-page: 401
  year: 1975
  ident: 10.5021/ad.2017.29.3.321_ref14
  publication-title: J Invest Dermatol
  doi: 10.1111/1523-1747.ep12512335
– volume: 36
  start-page: 220
  issue: Suppl 1
  year: 1998
  ident: 10.5021/ad.2017.29.3.321_ref5
  publication-title: Med Mycol
– volume: 43
  start-page: 2824
  year: 2005
  ident: 10.5021/ad.2017.29.3.321_ref10
  publication-title: J Clin Microbiol
  doi: 10.1128/JCM.43.6.2824-2829.2005
– volume: 26
  start-page: 733
  year: 2014
  ident: 10.5021/ad.2017.29.3.321_ref8
  publication-title: Ann Dermatol
  doi: 10.5021/ad.2014.26.6.733
– volume: 59
  start-page: 274
  year: 2016
  ident: 10.5021/ad.2017.29.3.321_ref16
  publication-title: Mycoses
  doi: 10.1111/myc.12456
– volume: 53
  start-page: 1092
  year: 2016
  ident: 10.5021/ad.2017.29.3.321_ref25
  publication-title: J Food Sci Technol
  doi: 10.1007/s13197-015-2131-6
– volume: 58
  start-page: 235
  year: 1996
  ident: 10.5021/ad.2017.29.3.321_ref13
  publication-title: Cutis
– volume: 25
  start-page: 2017
  year: 1987
  ident: 10.5021/ad.2017.29.3.321_ref9
  publication-title: J Clin Microbiol
  doi: 10.1128/JCM.25.10.2017-2019.1987
– volume: 128
  start-page: 345
  year: 2008
  ident: 10.5021/ad.2017.29.3.321_ref3
  publication-title: J Invest Dermatol
  doi: 10.1038/sj.jid.5701017
– volume: 90
  start-page: 442
  year: 2000
  ident: 10.5021/ad.2017.29.3.321_ref26
  publication-title: J Biosci Bioeng
  doi: 10.1016/S1389-1723(01)80016-5
– volume: 21
  start-page: 417
  year: 2003
  ident: 10.5021/ad.2017.29.3.321_ref2
  publication-title: Clin Dermatol
  doi: 10.1016/j.clindermatol.2003.08.003
– volume: 1
  start-page: 547
  year: 1998
  ident: 10.5021/ad.2017.29.3.321_ref19
  publication-title: Curr Opin Microbiol
  doi: 10.1016/S1369-5274(98)80087-8
– volume: 15
  start-page: 133
  year: 2002
  ident: 10.5021/ad.2017.29.3.321_ref1
  publication-title: Curr Opin Infect Dis
  doi: 10.1097/00001432-200204000-00006
– volume: 36
  start-page: 74
  year: 2014
  ident: 10.5021/ad.2017.29.3.321_ref23
  publication-title: Int J Cosmet Sci
  doi: 10.1111/ics.12098
– volume: 23
  start-page: 156
  year: 2011
  ident: 10.5021/ad.2017.29.3.321_ref4
  publication-title: Ann Dermatol
  doi: 10.5021/ad.2011.23.2.156
– volume: 15
  start-page: 434
  year: 2002
  ident: 10.5021/ad.2017.29.3.321_ref11
  publication-title: Skin Pharmacol Appl Skin Physiol
  doi: 10.1159/000066452
– volume: 27
  start-page: 518
  year: 2004
  ident: 10.5021/ad.2017.29.3.321_ref24
  publication-title: Arch Pharm Res
  doi: 10.1007/BF02980125
– volume: 56
  start-page: 571
  year: 2013
  ident: 10.5021/ad.2017.29.3.321_ref6
  publication-title: Mycoses
  doi: 10.1111/myc.12076
– reference: 9360056 - Drugs. 1997 Nov;54(5):657-78
– reference: 17671514 - J Invest Dermatol. 2008 Feb;128(2):345-51
– reference: 22970742 - Int J Cosmet Sci. 2013 Feb;35(1):78-83
– reference: 23496653 - Mycoses. 2013 Sep;56(5):571-5
– reference: 8834867 - Antimicrob Agents Chemother. 1996 Feb;40(2):279-91
– reference: 12476017 - Skin Pharmacol Appl Skin Physiol. 2002 Nov-Dec;15(6):434-41
– reference: 19170157 - Phytother Res. 2009 Aug;23(8):1190-3
– reference: 21747613 - Ann Dermatol. 2011 May;23(2):156-61
– reference: 237965 - J Invest Dermatol. 1975 Jun;64(6):401-5
– reference: 15541087 - Br J Dermatol. 2004 Nov;151(5):1071-5
– reference: 15202557 - Arch Pharm Res. 2004 May;27(5):518-23
– reference: 11964913 - Curr Opin Infect Dis. 2002 Apr;15(2):133-42
– reference: 25473226 - Ann Dermatol. 2014 Dec;26(6):733-8
– reference: 17520465 - J Dermatolog Treat. 2007;18(2):88-96
– reference: 12353705 - Acta Derm Venereol. 2002;82(3):170-3
– reference: 9988511 - Med Mycol. 1998;36 Suppl 1:220-9
– reference: 15956404 - J Clin Microbiol. 2005 Jun;43(6):2824-9
– reference: 10066533 - Curr Opin Microbiol. 1998 Oct;1(5):547-57
– reference: 14678722 - Clin Dermatol. 2003 Sep-Oct;21(5):417-25
– reference: 26786542 - Mycoses. 2016 May;59(5):274-80
– reference: 24117781 - Int J Cosmet Sci. 2014 Feb;36(1):74-8
– reference: 8886540 - Cutis. 1996 Sep;58(3):235-7
– reference: 16232887 - J Biosci Bioeng. 2000;90(4):442-6
– reference: 999300 - Arch Dermatol. 1976 Sep;112(9):1245-8
– reference: 3667925 - J Clin Microbiol. 1987 Oct;25(10):2017-9
– reference: 27162389 - J Food Sci Technol. 2016 Feb;53(2):1092-100
SSID ssj0061271
Score 2.1482518
Snippet A new shampoo with anti- properties obtained from various plants is required to provide seborrheic dermatitis patients with a wider range of treatment options....
A new shampoo with anti-Malassezia properties obtained from various plants is required to provide seborrheic dermatitis patients with a wider range of...
Background: A new shampoo with anti-Malassezia properties obtained from various plants is required to provide seborrheic dermatitis patients with a wider range...
SourceID nrf
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 321
SubjectTerms Original
피부과학
Title In Vitro Anti- Malassezia Activity of Castanea crenata Shell and Oil-Soluble Glycyrrhiza Extracts
URI https://www.ncbi.nlm.nih.gov/pubmed/28566909
https://www.proquest.com/docview/1904901133
https://pubmed.ncbi.nlm.nih.gov/PMC5438939
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002227025
Volume 29
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX Annals of Dermatology, 2017, 29(3), , pp.321-326
journalDatabaseRights – providerCode: PRVBFR
  databaseName: Free Medical Journals
  customDbUrl:
  eissn: 2005-3894
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0061271
  issn: 1013-9087
  databaseCode: DIK
  dateStart: 20070101
  isFulltext: true
  titleUrlDefault: http://www.freemedicaljournals.com
  providerName: Flying Publisher
– providerCode: PRVERR
  databaseName: KoreaMed Open Access
  customDbUrl:
  eissn: 2005-3894
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0061271
  issn: 1013-9087
  databaseCode: 5-W
  dateStart: 20060101
  isFulltext: true
  titleUrlDefault: https://koreamed.org/journals
  providerName: Korean Association of Medical Journal Editors
– providerCode: PRVAQN
  databaseName: PubMed Central
  customDbUrl:
  eissn: 2005-3894
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0061271
  issn: 1013-9087
  databaseCode: RPM
  dateStart: 20080101
  isFulltext: true
  titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/
  providerName: National Library of Medicine
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLa6ISFeEHfKTQbxgqp0SZzr4zQG7VABiQ32ZpzYYdFKMqWpxPp_-R-c4zhpWk0I9pJWrhMnOV_PzedCyGtg-iKNJLOkr6TlgUJrCUCSpaLMD0KZprKJtvgYTE68o1P_dDD43YtaWtbJOF1dmVdyHarCGNAVs2T_g7LdRWEAvgN94QgUhuM_0XhajL7mdVViCYDcmmFK5EKtcjHaT01TCJ19hQqgEiPQDwtRi9EXjP3Umwaf8rmFfjHMnno_v0wvq-osX4nR4a8ak6cWfc11XWlZIjOvN9zxE-NGxcZFE9XDStWE5iNPKrucINPBGYePlkZyYhCP4TvfyqK7iPFHOOE6bmrcZrR9KCvcRnjb3c423rA9QW9iP0C1V15ER05tPlHDpLEjRWwbQa30mK6oCsqX1-fsxpeS9w1_zaZZk5VtJD5rcva3hYkP6g9KSqwn64RjNx6zsTmxh62LnxpcbgR6cWzHa7HaBTt-nh342GOexTvkhhsGgds6lRqFAXTMxi_QPlazm47L720vjrWrzUobitROUWVX2Ujbob493en4DrltjB663yD4Lhmo4h65OTNhHffJ92lBNZDpFpBpC2RaZrQFMjVAphrIFIBMe0CmPSDTFsgPyMm7w-ODiWVaf1gpi6IaRLDwtDvAEz6wmdAHMRyFGZN2mAY-2DRpEvuhsG0RsSARaDcnnh1nIlBZwgKbPSS7RVmox4SqJMvcMFbAhyRoYlJIx5FZJDwwJBLbUUOy175Hnpq6-NieZc7BPkYicCE5EoG7MWcciDAkb7ozLpqaMH-Z-wpIw8_TnGMhd_z8UfLzioO5OuUOAwU9ZEPysqUcB-6OW3bwOsvlgoO67mFyOIM5jxpKdku2QBiScIPG3QRccPOXIj_TFeQNHp9c-8yn5Nb6v_-M7NbVUj0H7bxOXmhs_wG5W-e6
linkProvider National Library of Medicine
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=In+Vitro+Anti-Malassezia+Activity+of+Castanea+crenata+Shell+and+Oil-Soluble+Glycyrrhiza+Extracts&rft.jtitle=Annals+of+dermatology&rft.au=Han%2C+Song+Hee&rft.au=Hur%2C+Min+Seok&rft.au=Kim%2C+Min+Jung&rft.au=Jung%2C+Won+Hee&rft.date=2017-06-01&rft.pub=The+Korean+Dermatological+Association%3B+The+Korean+Society+for+Investigative+Dermatology&rft.issn=1013-9087&rft.eissn=2005-3894&rft.volume=29&rft.issue=3&rft.spage=321&rft.epage=326&rft_id=info:doi/10.5021%2Fad.2017.29.3.321&rft_id=info%3Apmid%2F28566909&rft.externalDocID=PMC5438939
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1013-9087&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1013-9087&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1013-9087&client=summon